Demand for home healthcare, including at-home hospice care, has skyrocketed since the onset of the COVID pandemic, as has the number of family caregivers.

By bringing Exact Sciences into the fold, the expectation is that the focus on cancer diagnostics can provide a jolt to the ...

Fighting invasive oral cancer at age 51 forced Sonya Sotinsky to confront the existential importance of the human voice.

U.S. set to unveil 15 new Medicare-negotiated drug prices; U.S.-U.K. drug pricing deal could be unveiled; Louisiana surgeon general tapped as deputy director at CDC.

Next year, average enrollee premium payments in the FEHB system are set to jump more than 12%, on top of a 13.5% hike in 2025.

Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural moments.

M&C Saatchi revenues hit by US government shutdown while S4 Capital blames 'lower project-based revenue and continued client caution'.

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.

Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family; Merck buys Cidara; ByHeart’s ...

AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) was approved in the U.S. for the treatment of adult ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.